Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. - Dahlöf,B.; Devereux,R.B.; Kjeldsen,S.E.; Julius,S.; Beevers,G.; Faire,U.; Fyhrquist,F.; Ibsen,H.; Kristiansson,K.; Lederballe-Pedersen,O.; Lindholm,L.H.; Nieminen,M.S.; et al. (Lancet, 2002)